Evidence map›Paper›PMID 18166776›Full record

ArticleHaematologica2008

Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!

Mark T Gladwin, Gregory J Kato

Abstract readCommentEditorial
In one paragraph

Article in Haematologica, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Linking Labile Heme with Thrombosis.Journal of clinical medicine · 2021
    Review
  5. Article
  6. Review
  7. Article
  8. Mechanisms of hemolysis-associated platelet activation.Journal of thrombosis and haemostasis : JTH · 2013
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Mark T Gladwin
Gregory J Kato

Funding

Prevalence and Prognosis of Pulmonary Hypertension in Adults with Sickle CellZIAHL006012 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI TAYLOR, JAMES · 2009 to 2016
$3.5M
Natural History of Sickle Cell Disease and Other Hemolytic DisordersZIAHL006014 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KATO, GREGORY · 2009 to 2014
$2.7M
Intramural NIH HHS ZIA HL006012Intramural NIH HHS ZIA HL006014
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HemolysisAnemia, Sickle CellEndothelial CellsFibrinFlow CytometryHemostasisHumansHypertension, PulmonaryInflammationModels, BiologicalMonocytesThrombophiliaFibrin

Identifiers

PMID18166776
PMCPMC4263346

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.